March 12, 2019
Working group meeting on functional precision medicine in Vienna, Austria.
Excellent science, here by Dr. Tony Letai, followed by a proper Austrian dinner. >>read more
standards precision medicine member
February 25, 2019
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Tumor organoids maintain cell–cell interactions, heterogeneity, microenvironment, and drug response of the sample they originate from. Thus, there is increasing interest in developing tumor organoid models for drug development and personalized medicine applications. Although organoids are in principle amenable to high-throughput screenings, progress has been hampered by technical constraints and extensive manipulations required by current methods. >>read more
soragni:lab biology member